USD 2.86 Billion
Report ID:
SQMIG35H2314 |
Region:
Global |
Published Date: November, 2024
Pages:
214
|Tables:
85
|Figures:
71
Gene Panel Market size was valued at USD 2.86 Billion in 2023 and is poised to grow from USD 3.41 Billion in 2024 to USD 14.02 Billion by 2032, growing at a CAGR of 19.30% during the forecast period (2025-2032).
The quick development of personalized medicine and genetic technologies. Gene panels are now more reasonably priced due to the decline in the cost of genomic sequencing, which makes comprehensive genetic testing and analysis of a broad variety of illnesses possible. The rising incidence of hereditary diseases and the expanding demand for precise, customized treatment plans are driving this expansion. Additionally, as gene panels offer helpful insights into genetic predispositions and potential treatment options, their growing application in research, diagnostics, and therapeutic development is propelling market expansion. The global gene panel market growth is being driven by rapid advancements in genomics and personalized medicine.
A gene panel is a collection of genes examined collectively to identify genetic variations associated with conditions or disorders. Gene panels are utilized in illness research, personalized medicine, and genetic condition diagnostic testing. They make it possible to effectively and selectively investigate multiple genes at once, shedding light on hereditary illnesses and assisting in the creation of tailored treatment plans. Gene panels have a bright future ahead of them due to continuous advancements in bioinformatics and sequencing technology, which will increase their applicability and precision, facilitate their incorporation into standard clinical practice, and increase their usage in both therapeutic and preventive settings.
Market snapshot - 2025-2032
Global Market Size
USD 2.86 Billion
Largest Segment
Amplicon-based Approach
Fastest Growth
Hybridization-based Approach
Growth Rate
19.30% CAGR
To get more reports on the above market click here to Buy The Report
Global Gene Panel Market is segmented by Product and Services, Technique, Design, Application, End User and Region. Based on Product and Services, the market is segmented into Test Kits, and Testing Services. Based on Technique, the market is segmented into Amplicon-based Approach, and Hybridization-based Approach. Based on Design the market is segmented into Predesigned Gene Panel, and Customized Gene Panel. Based on Application, the market is segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, and Pharmacogenetics. Based on end user, the market is segmented into Research and Academic Institutes, Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
As per categorization by product and services, the market is classified as amplicon-based approach and hybridization-based approach. Among these, amplicon-based approach earned the largest share and continues to dominate the market. The Amplicon-based Approach has been the most prosperous in the global gene panel market. This is attributed to improvements in PCR methods that enhance sensitivity and specificity for targeted genetic analysis. The low cost of the technique, its easy application and reliability in detecting specific genetic variants are also some of the reasons for its popularity as a tool for precise and expedient genomic testing.
The Hybridization-based Approach is set to be the fastest-growing segment in the global gene panel market due to its ability to analyze a broad spectrum of genetic variations through high-throughput techniques. It supports the development of personalized medicine and discovery of biomarkers through its ability to provide holistic genomic profiling. This is likely to be accompanied by an influx of hybridization systems that can evolve constantly because of the rising need for more detailed genetic information.
Doctor & Testing Laboratories lead gene panel revolution with use of new sequencing methods enhancing test accuracy for individuals' treatment. Their key position in the global gene panel market comes from their essential part in the medicine diagnosis field hence making people require trustworthy, specific genetic examination results when it comes to taking care of patients.
In terms of speed in growth, the pharmaceutical and biotechnology organizations will take lead as they invest a lot in intensive research and development while emphasizing genetic information for discovering medications as well as individualized medicine. Advanced gene panels help scientists identify biomarkers which in turn accelerates the drug creation process. That is why the two industries pursue innovative therapies together with targeted treatments. Therefore, through their incessant pursuit of genomic research, these companies accelerate the expansion of the said market segment.
To get detailed analysis on other segments, Request For Free Sample Report
North America dominates the global gene panel market due to its advanced healthcare infrastructure, high investment in biotechnology research, and a strong focus on personalized medicine. Through the allocation of massive funds for genomic research within this region, one can observe that there are strong regulatory structures already in place as well as a high uptake of advanced technologies. Demand for complex gene panels in the US and Canadian regions is primarily driven by major pharmaceutical and biotechnology firms which have a solid network of hospitals and diagnostic laboratories. Other than that, the gene panel industry continues to grow due to North America's conducive policy environment and collaboration among researchers thereby fostering innovation.
Europe is the fastest-growing region in the global gene panel market due to increasing investments in genomic research and advancements in healthcare technologies. A powerful government assistance and finances made available for scientific inquiry have made this region a gainer considering developments in individualized pharmacotherapy and accurate medical treatment. The innovation engine of Europe is driven by its collaborative research system characterized by partnerships between academic institutions and biotech companies. Besides that, healthcare system expansion as well as increased use of gene panels during diagnosis procedures or pharmaceutical drug creation are some reasons why Europe has been experiencing unprecedented growth making it one of the most vibrant markets involved with gene panel use.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Advances in Sequencing Technologies
Rising Demand for Personalized Medicine
Limited Awareness and Education
Variability in Test Accuracy and Interpretation
Request Free Customization of this report to help us to meet your business objectives.
Global gene panel market is competitive with key players who drive innovations and expand markets. To keep up with the high demand for personalized medicine, rapid technological advancements have continued fueling competition among these companies that specialize in gene panels like Illumina, Thermo Fisher Scientific or Agilent Technologies and offer advanced sequencing technologies in addition to complete solutions for gene panels. Fast technology progressions and a growing desire for individualized treatment are spurring on going innovations as well as frequent expansion in the market.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global gene panel market is experiencing significant growth driven by advancements in genomic technologies and personalized medicine. Genomic sequencing costs have decreased, making broad assessments of genes cheaper, hence ensuring accessible and expanded personalized treatments & better patient outcomes. This is furthered by the rise in inherited disorders and the need for select therapies.
Despite challenges such as high costs and variable test accuracy, innovations in sequencing technologies and the adoption of AI are advancing the field. As gene panels become integral in research, diagnostics, and therapeutic development, their future remains promising with continued advancements enhancing their clinical applications.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 2.86 Billion |
Market size value in 2032 | USD 14.02 Billion |
Growth Rate | 19.30% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Gene Panel Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Gene Panel Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Gene Panel Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Gene Panel Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Gene Panel Market size was valued at USD 2.86 Billion in 2023 and is poised to grow from USD 3.41 Billion in 2024 to USD 14.02 Billion by 2032, growing at a CAGR of 19.30% during the forecast period (2025-2032).
Global gene panel market is competitive with key players who drive innovations and expand markets. To keep up with the high demand for personalized medicine, rapid technological advancements have continued fueling competition among these companies that specialize in gene panels like Illumina, Thermo Fisher Scientific or Agilent Technologies and offer advanced sequencing technologies in addition to complete solutions for gene panels. Fast technology progressions and a growing desire for individualized treatment are spurring on going innovations as well as frequent expansion in the market. 'Qiagen ', 'Roche ', 'Illumina ', 'Thermo Fisher Scientific ', 'Agilent Technologies ', 'Bio-Rad Laboratories ', 'PerkinElmer ', 'Becton, Dickinson and Company (BD) ', 'Sangamo Therapeutics ', 'Genomics England ', 'Personalis, Inc. ', 'Twist Bioscience Corporation ', 'Castle Biosciences, Inc ', 'Neogenomics Laboratories ', 'NantHealth ', 'Macrogen ', 'Myrtelle Inc. ', 'Eurofins Genomics ', 'Guardant Health, Inc. ', 'Myriad Genetic Laboratories Inc.'
The global gene panel market is being driven by innovations of next-generation sequencing (NGS) technologies that offer better precision, increased pace and cost savings for genetic analysis. This has made it possible to have extensive genomic profiling and thus encourage personalization of medicine hence stimulating the demand for gene panels in clinical and research applications.
Surge in Personalized Medicine Adoption: Personalized medicine is on the rise in the global gene panel market as healthcare practitioners are using gene panels more frequently for customized treatment approaches. Such a trend that has been fueled by advancements in genomics has enabled better diagnostics and focused therapies that can improve patients’ health outcomes thus boosting demand for these products.
North America dominates the global gene panel market due to its advanced healthcare infrastructure, high investment in biotechnology research, and a strong focus on personalized medicine. Through the allocation of massive funds for genomic research within this region, one can observe that there are strong regulatory structures already in place as well as a high uptake of advanced technologies. Demand for complex gene panels in the US and Canadian regions is primarily driven by major pharmaceutical and biotechnology firms which have a solid network of hospitals and diagnostic laboratories. Other than that, the gene panel industry continues to grow due to North America’s conducive policy environment and collaboration among researchers thereby fostering innovation.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35H2314
[email protected]
USA +1 351-333-4748